Mammary stem and progenitor cell regulation

Cancer Biomarkers

Volumn 3, Issue 4-5, 2007, Pages 171-181

  Glazer, Robert I ^a,b   Wang, Xiaoyang ^a   Yuan, Hongyan ^a   Yin, Yuzhi ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Estrogen receptor ; Mammary tumorigenesis; Musashi1; Peroxisome proliferator activated receptor (PPAR ); Stem cell antigen 1 (Sca 1)

Indexed keywords

ANTIESTROGEN; BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOKERATIN 14; CYTOKERATIN 18; ESTROGEN RECEPTOR; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; HERMES ANTIGEN; IMATINIB; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NOTCH RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROGESTERONE RECEPTOR; PROTEIN KINASE B; RAS PROTEIN; RETINOID X RECEPTOR; STAT PROTEIN; STEM CELL ANTIGEN 1; T CELL FACTOR PROTEIN; UNINDEXED DRUG; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER STEM CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CELL SURFACE; CHRONIC MYELOID LEUKEMIA; DRUG EFFICACY; DRUG TARGETING; HEMATOPOIETIC STEM CELL; HUMAN; MULTIPOTENT STEM CELL; NONHUMAN; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; EPITHELIUM CELL; MAMMARY GLAND; PHYSIOLOGY; STEM CELL; UDDER;

ANIMALS; CELL DIFFERENTIATION; EPITHELIAL CELLS; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 38449099002     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2007-34-502     Document Type: Review

References (132)

1. H. Kalirai and R.B. Clarke, Human breast epithelial stem cells and their regulation, J Pathol 208 (2006), 7-16.
2. T. Reya, S.J. Morrison, M.F. Clarke and I.L. Weissman, Stem cells, cancer, and cancer stem cells, Nature 414 (2001), 105-111.
3. M.F. Clarke and M. Fuller, Stem cells and cancer: Two faces of Eve, Cell 124 (2006), 1111-1115.
4. M.D. Henry, A.A. Triplett, K.B. Oh, G.H. Smith and K.U. Wagner, Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice, Oncogene 23 (2004), 6980-6985.
5. G. de Haan and G. Van Zant, Intrinsic and extrinsic control of hemopoietic stem cell numbers: Mapping of a stem cell gene, J Exp Med 186 (1997), 529-536.
6. T. Hamaguchi, Y. Matsuoka, H. Kawaguchi et al., Terminal endbuds and acini as the respective major targets for chemical and sporadic carcinogenesis in the mammary glands of human c-Ha-ras protooncogene rats, Breast Cancer Res Treat 83 (2004), 43-56.
7. L. Sivaraman, J. Gay, S.G. Hilsenbeck et al., Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis, Breast Cancer Res Treat 73 (2002), 75-93.
8. W. Boecker and H. Buerger, Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept, Cell Prolif 36 Suppl 1) (2003), 73-44.
9. D. Medina, F.S. Kittrell, A. Shepard, A. Contreras, J.M. Rosen and J. Lydon, Hormone dependence in premalignant mammary progression, Cancer Res 63 (2003), 1067-1072.
10. G. Chepko and G.H. Smith, Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal, Tissue Cell 29 (1997), 239-253.
11. G. Shyamala, X. Yang, R.D. Cardiff and E. Dale, Impact of progesierone receptor on cell-fate decisions during mammary gland development, Proc Natl Acad Sci USA 97 (2000), 3044-3049.
12. J.P. Lydon, G. Ge, F.S. Kittrell, D. Medina and B.W. O'Malley, Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function, Cancer Res 59 (1999), 4276-4284.
13. Y. Yin, R. Bai, R.G. Russell et al., Characterization of medroxyprogesterone and DMBA-induced multilineage mammary rumors by gene expression profiling, Mol Carcinog 44 (2005), 42-50.
14. C. Pechoux, T. Gudjonsson, L. Ronnov-Jessen, M.J. Bissell and O.W. Petersen, Human mammary luminal epithelial cells contain progenitors to myoepithelial cells, Dev Biol 206 (1999), 88-99.
15. W.A. Woodward, M.S. Chen, F. Behbod and J.M. Rosen, On mammary stem cells, J Cell Sci 118 (2005), 13585-3594.
16. K.B. DeOme, L.J. Faulkin, H.A. Bern and P.B. Blair, Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice, Cancer Res 19 (1959), 515-520.
17. D.C. Bennett, L.A. Peachey, H. Durbin and P.S. Rudland, A possible mammary stem cell line, Cell 15 (1978), 283-298.
18. K.G. Danielson, C.J. Oborn, E.M. Durban, J.S. Butel and D. Medina, Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro, Proc Natl Acad Sci USA 81 (1984), 3756-3760.
19. M.A. Deugnier, M.M. Faraldo, J. Teuliere, J.P. Thiery, D. Medina and M.A. Glukhova, Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line, Dev Biol (2006).
20. G.H. Smith and D. Medina, A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland, J Cell Sci 90 Pt 1) (1988), 173-183.
21. G.H. Smith, Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype, Breast Cancer Res Treat 39 (1996), 21-31.
22. E.C. Kordon and G.H. Smith, An entire functional mammary gland may comprise the progeny from a single cell, Development 125 (1998), 1921-1930.
23. G. Chepko and G.H. Smith, Mammary epithelial stem cells: Our current understanding, J Mammary Gland Biol Neoplasia 4 (1999), 35-52.
24. G.H. Smith and G. Chepko, Mammary epithelial stem cells, Microsc Res Tech 52 (2001), 190-203.
25. R.Y. Tsai, A molecular view of stem cell and cancer cell self-renewal, Int J Biochem Cell Biol 36 (2004), 684-694.
26. G.H. Smith, Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands, Development 132 (2005), 681-687.
27. N. Zeps, J.M. Bentel, J.M. Papadimitriou, M.F. D'Antuono and H.J. Dawkins, Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth, Differentiation 62 (1998), 221-226.
28. B.W. Booth and G.H. Smith, Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands, Breast Cancer Res 8 (2006), R49.
29. R.B. Clarke, K. Spence, E. Anderson, A. Howell, H. Okano and C.S. Potten, A putative human breast stem cell population is enriched for steroid receptor-positive cells, Dev Biol 277 (2005), 443-456.
30. K.E. Sleeman, H. Kerdrick, D. Robertson, C.M. Isacke, A. Ashworth and M.J. Smalley Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland, J Cell Biol 176 (2007), 19-26.
31. I. Baik, W.J. Devito, K. Ballen et al., Association of fetal hormone levels with stem cell potential: Evidence for early life roots of human cancer, Cancer Res 65 (2005), 358-363.
32. M.A. Goodell, K. Brose, G. Paradis, A.S. Conner and R.C. Mulligan, isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo, J Exp Med 183 (1996), 1797-1806.
33. S. Zhou, J.D. Schuetz, K.D. Buitting et al., The ABC transporter Bcrp1/ ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, Nat Med 7 (2001),1028-1034.
34. B.E. Welm, S.B. Tepera, T. Venezia, T.A. Graubert, J.M. Rosen and M.A. Goodell, Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population, Dev Biol 245 (2002), 42-56.
35. A.J. Alvi, H. Clayton, C. Joshi et al., Functional and molecular characterisation of mammary side population cells, Breast Cancer Res 5 (2003), R1-R8.
36. N. Uchida, B. Dykstra, K. Lyons, F. Leung, M. Kristiansen and C. Eaves, ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status, Blood 103 (2004), 4487-4495.
37. K.U. Wagner, C.A. Boulanger, M.D. Henry, M. Sgagias, L, Hennighausen and G.H. Smith, An adjunct mammary epithelial cell population in parous females: Its role in functional adaptation and tissue renewal, Development 129 (2002), 1377-1386.
38. F.J. Sharom and M.T. Lehto, Glycosylphosphatidylinositol-anchored proteins: Structure, function, and cleavage by phosphatidylinositol-specific phospholipase C, Biochem Cell Biol 80 (2002), 535-549.
39. M. van de Rijn, S. Heimfeld, G.J. Spangrude and I.L. Weissman, Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family, Proc Natl Acad Sci USA 86 (1989), 4634-4638.
40. J.E. Darrnell Jr., I.M. Kerr and G.R. Stark, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science 764 (1994), 1415-1421.
41. A.M. Sinclair and E.A. Dzierzak, Cloning of the complete Ly-6E.1 gene and identification of DNase I hypersensitive sites corresponding to expression in hematopoietic cells, Blood 82 (1993), 3052-3062.
42. B. Su, G.L. Waneck, R.A. Flavell and A.L. Bothwell, The glycosyl phosphatidylinositol anchor is critical for Ly-6A/E- mediated T cell activation, J Cell Biol 112 (1991), 377-384.
43. H.C. Chen, F. Frissora, J.E. Durbin and N. Muthusamy, Activation induced differential regulation of stem cell antigen-1 (Ly-6A/E) expression in murine B cells, Cell Immunol 225 (2003), 42-52.
44. M.M. Khodadoust, K.D. Khan and A.L. Bothwell, Complex regulation of Ly-6E gene transcription in T cells by IFNS, J Immunol 163 (1999), 811-819.
45. X. Ma, K.W. Ling and E. Dzierzak, Cloning of the Ly-6A (Sca-1) gene locus and identification of a 3′ distal fragment responsible for high-level gamma-interferon-induced expression in vitro, Br J Haematol 114 (2001), 724-730.
46. H.B. Sadowski, K. Shuaj, J.E. Darnell Jr. and M.Z. Gilman, A common nuclear signal transduction pathway activated by growth factor and cytokine receptors, Science 261 (1993), 1739-1744.
47. A. Linke, P. Muller, D. Nurzynska et al., Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function, Proc Natl Acad Sci USA 102 (2005), 8966-8971.
48. P.O. Mitchell, T. Mills, R.S. O'Connor, T. Graubert, E. Dzierzak and G.K. Pavlath, Sca-1 negatively regulates proliferation and differentiation of muscle cells, Dev Biol 283 (2005), 240-252.
49. Y. Li and J.M. Rosen, Stem/progenitor cells in mouse mammary gland development and breast cancer, J Mammary Gland Biol Neoplasia 10 (2005), 17-24.
50. G. Luna, J. Paez and I.E. Cardier, Expression of the hematopoietic stem cell antigen Sca-1 (LY-6A/E) in liver sinusoidal endothelial cells: possible function of Sca-1 in endothelial cells, Stem Cells Dev 13 (2004), 528-535.
51. P.E. Burger, X. Xiong, S. Coetzee et al., Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue, Proc Natl Acad Sci USA 102 (2005), 7180-7185.
52. T.R. Malek, G. Ortega, C. Chan, R.A. Kroczek and E.M. Shevach, Role of Ly-6 in lymphocyte activation. II. Induction of T cell activation by monoclonal anti-Ly-6 antibodies, J Exp Med 164 (1986), 709-722.
53. C.L. Epting, J.E. Lopez, X. Shen, L. Liu, J. Bristow and H.S. Bernstein, Stem cell antigen-1 is necessary for cell-cycle withdrawal and myoblast differentiation in C2C12 cells, J Cell Sci 117 (2004), 6185-6195.
54. Y. Wang, J. Dang, L.K. Johnson, J.J. Selhamer and W.F. Doe, Structure of the human urokinase receptor gene and its similarity to CD59 and the Ly-6 family, Eur J Biochem 227 (1995), 116-122.
55. S.B. Bradfute, T.A. Graubert and M.A. Goodell, Roles of Sca-1 in hematopoietic stem/progenitor cell function, Exp Hematol 33 (2005), 836-843.
56. S.C. Henderson, M.M. Kamdar and A. Bamezai, Ly-6A.2 expression regulates antigen-specific CD4+ T cell proliferation and cytokine production, J Immunol 168 (2002), 118-126.
57. G.B. Huffnagle, M.F. Lipscomb, J.A. Lovchik, K.A. Hoag and N.E. Street, The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection, J Leukoc Biol 55 (1994), 35-42.
58. W.L. Stanford, S. Haque, R. Alexander et al., Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice, J Exp Med 186 (1997), 705-717.
59. Z.X. Zhang, W.L. Stanford and L. Zhang, Ly-6A is critical for the function of double negative regulatory T cells, Eur J Immunol 32 (2002), 1584-1592.
60. K. Okumoto, T. Saito, E. Hattori et al., Differentiation of bone marrow cells into cells that express liver-specific genes in vitro: implication of the Notch signals in differentiation, Biochem Biophys Res Commun 304 (2003), 691-695.
61. B. Welm, F. Behbod, M.A. Goodell and J.M. Rosen, Isolation and characterization of functional mammary gland stem cells, Cell Prolif 36(Suppl 1) (2003), 17-32.
62. P. Hanson, V. Mathews, S.H. Marrus and T.A. Graubert, Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo, Exp Hematol 31 (2003), 159-167.
63. M. Smalley and A. Ashworth, Stem cells and breast cancer: A field in transit, Nat Rev Cancer 3 (2003), 832-844.
64. L. Xin, D.A. Lawson and O.N. Witte, The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis, Proc Natl Acad Sci USA 102 (2005), 6942-6947.
65. Y.S. Kwon, I. Garcia-Bassets, K.R. Hutt et al., Sensitive ChIP-DSL technology reveals an extensive estrogen receptor {alpha}-binding program on human gene promoters, Proc Natl Acad Sci USA 104 (2007), 4852-4857.
66. Y. Yin, H. Yuan, S. Mueller, L. Kopelovich and R.I. Glazer, Peroxisome proliferator-activated receptory is a regulator of mammary stem and progenitor cell self-renewal and estrogen receptor-dependent tumor specification. Proceedings of the American Association for Cancer Research, Los Angeles, CA, April 14-18, 2007.
67. K.E. Sleeman, H. Kendrick, A. Ashworth, C.M. Isacke and M.J. Smalley, CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells, Breast Cancer Res 8 (2006), R7.
68. M.L. Asselin-Labat, M. Shackleton, J. Stingl et al., Steroid hormone receptor status of mouse mammary stem cells, J Natl Cancer Inst 98 (2006), 1011-1014.
69. M. Shackleton, F. Vaillant, K.J. Simpson et al.. Generation of a functional mammary gland from a single stem cell, Nature 439 (2006), 84-88.
70. J. Stingl, P. Eirew, I. Ricketson et al., Purification and unique properties of mammary epithelial stem cells, Nature 439 (2006), 993-997.
71. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison and M.F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA 100 (2003), 3983-3988.
72. D. Ponti, A. Costa, N. Zaffaroni et al., Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties, Cancer Res 65 (2005), 5506-5511.
73. R. Liu, X. Wang, G.Y. Chen et al., The prognostic role of a gene signature from tumorigenic breast-cancer cells, N Engl J Med 356 (2007), 217-226.
74. M. Shipitsin, L.L. Campbell, P. Argani et al., Molecular definition of breast tumor heterogeneity, Cancer Cell 11 (2007), 259-273.
75. R. Pardal, M.F. Clarke and S.J. Morrison, Applying the principles of stem-cell biology to cancer, Nat Rev Cancer 3 (2003), 895-902.
76. M. Baron, An overview of the Notch signalling pathway, Semin Cell Dev Biol 14 (2003), 113-119.
77. H. Okano, T. Imai and M. Okabe, Musashi: A translational regulator of cell fate, J Cell Sci 115 (2002), 1355-1359.
78. M.A. McGill and C.J. McGlade, Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain, J Biol Chem (2003).
79. Y. Wakamatsu, T.M. Maynard, S.U. Jones and J.A. Weston, NUMB localizes in the basal cortex of mitotic avian neuroepithelial cells and modulates neuronal differentiation by binding to NOTCH-1, Neuron 23 (1999), 71-81.
80. T. Imai, A. Tokunaga, T. Yoshida et al., The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA, Mol Cell Biol 21 (2001), 3888-3900.
81. C. Battelli, G.N. Nikopoulos, J.G. Mitchell and J.M. Verdi, The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1, Mol Cell Neurosci 31 (2006), 85-96.
82. S. Pece, M. Serresi, E. Santolini et al., Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis, J Cell Biol 167 (2004), 215-221.
83. S. Stylianou, R.B. Clarke and K. Brennan, Aberrant activation of notch signaling in human breast cancer, Cancer Res 66 (2006), 1517-1525.
84. S. Sakakibara, T. Imai, K. Hamaguchi et al., Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell, Dev Biol 176 (1996), 230-242.
85. R.B. Clarke, E. Anderson, A. Howell and C.S. Potten, Regulation of human breast epithelial stem ceils, Ceil Prolif 36(Suppl 1) (2003), 45-58.
86. K. Fitzgerald, A. Harrington and P. Leder, Ras pathway signals are required for notch-mediated oncogenesis, Oncogene 19 (2000 , 4191-4198.
87. C. Jhappan, D. Gallahan, C. Stahle et al., Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands, Genes Dev 6 (1992), 345-355.
88. C. Hu, A. Dievart, M. Lupien, E. Calvo, G. Tremblay and P. Jolicoeur, Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors, Am J Pathol 168 (2006), 973-990.
89. G. Dontu, W.M. Abdallah, J.M. Foley et al., In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells, Genes Dev 17 (2003), 1253-1270.
90. G. Dontu, K.W. Jackson, E. McNicholas, M.J. Kawamura, W.M. Abdallah and M.S. Wicha, Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells, Breast Cancer Res 6 (2004), R605-R615.
91. G.H. Smith, R. Sharp, E.C. Kordon, C. Jhappan and G. Merlino, Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells, Am J Pathol 147 (1995), 1081-1096.
92. R.B. Clarke, Isolation and characterization of human mammary stem cells, Cell Prolif 38 (2005), 375-386.
93. T. Reya and H. Clevers, Wnt signalling in stem cells and cancer, Nature 434 (2005), 843-850.
94. J. Behrens, J.P. von Kries, M. Kuhl et al., Functional interaction of beta-catenin with the transcription factor LEF-1, Nature 382 (1996), 638-642.
95. M.D. Gordon and R. Nusse, Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors, J Biol Chem 281 (2006), 22429-22433.
96. J. Taipale and P.A. Beachy, The Hedgehog and Wnt signalling pathways in cancer, Nature 411 (2001), 349-354.
97. H. Shimizu, M.A. Julius, M. Giarre, Z. Zheng, A.M. Brown and J. Kitajewski, Transformation by Wnt family proteins correlates with regulation of beta-catenin, Cell Growth Differ 8 (1997), 1349-1358.
98. R. Nusse and H.E. Varmus, Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome, Cell 31 (1982), 99-109.
99. K. Orford, C. Crockett, J.P. Jensen, A.M. Weissman and S.W. Byers, Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin, J Biol Chem 272 (1997), 24735-24738.
100. D. Cook, M.J. Fry, K. Hughes, R. Sumathipala, J.R. Woodgett and T.C. Dale, Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C, Embo J 15 (1996), 4526-4536.
101. R.H. Chen, W.V. Ding and F. McCormick, Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C, J Biol Chem 275 (2000), 17894-17899.
102. D. Kim, O. Rath, W. Kolch and K.H. Cho, A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways, Oncogene (2007).
103. A. Imbert, R. Eelkema, S. Jordan, H. Feiner and P. Cowin, Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland, J Cell Biol 153 (2001), 555-568.
104. A.S. Tsukamoto, R. Grosschedl, R.C. Guzman, T. Parslow and H.E. Varinus, Expression the int-i gene in transgenic mice is associated with manimary gland hyperplasia and adenocarcinomas in male and female mice, Cell 55 (1988), 619-625.
105. Z. Xie, H. Yuan, Y Yin, X. Zeng, R. Bai and R.I. Glazer, 3-Phosphoinositide-dependent Protein Kinase-1 (PDKI) Promotes Invasion and Activation of Matrix Metalloproteinases, BMC Cancer 6 (2006), 77.
106. Z. Xie, X. Zeng, T. Waldman and R.I. Glazer, Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1, Cancer Res 63 (2003), 5370-5375.
107. X. Zeng, H. Xu, B.-K. Park and R.I. Glazer, Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of prolein kinase Cα, Cancer Res 62 (2002), 3538-3543.
108. Y. Yin, S.T. Kristipati, H. Yuan, L. Kopelovich and R.I. Glazer, Modulation of stem cell antigen (Sca-1) expression by the PDK1 and Stat pathways, Proceedings of the American Association for Cancer Research, Washington, DC, April 1-4, 2006.
109. Y. Li, B. Welm, K. Podsypanina et al., Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells, Proc Natl Acad Sci USA 100 (2003), 15853-15858.
110. B.Y. Liu, S.P. McDermott, S.S. Khwaja and C.M. Alexander, The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells, Proc Natl Acad Sci USA 101 (2004), 4158-4163.
111. S. Naylor, M.J. Smalley, D. Robertson, B.A. Gusterson, P.A. Edwards and T.C. Dale, Retroviral expression of Wnt-1 and Wnt-7b produces different effects in mouse mammary epithelium, J Cell Sci 113(Pt 12) (2000), 2129-2138.
112. T. Miyabayashi, J.L. Teo, M. Yamamoto, M. McMillan, C. Nguyen and M. Kahn, Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency, Proc Natl Acad Sci USA 104 (2007), 5668-5673.
113. S.L. Etheridge, G.J. Spencer, D.J. Heath and P.G. Genever, Expression profiling and functional analysis of wnt signaling mechaisms in mesenchymal stem cells, Stem Cells 22 (2004), 849-860.
114. J.P. Berger, T.E. Akiyama and P.T. Meinke, PPARs: Therapeutic targets for metabolic disease, Trends Pharmacol Sci 26 (2005), 244-251.
115. T.M. Willson, P.J. Brown, D.D. Stembach and B.R. Henke, The PPARs: From orphan receptors to drug discovery, J Med Chem 43 (2000), 527-550.
116. L. Michalik, B. Desvergne and W. Wahli, Peroxisome-proliferator-activated receptors and cancers: Complex stories, Nat Rev Cancer 4 (2004), 61-70.
117. C. Grommes. G.E. Landreth and M.T. Heneka, Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists, Lancet Oncol 5 (2004), 419-429.
118. H. Keller, F. Givel, M. Perroud and W. Wahli, Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements, Mol Endocrinol 9 (1995), 794-804.
119. D. Bonofiglio, S. Gabriele, S. Aquila et al., Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. Clin Cancer Res 11 (2005). 6139-6147.
120. L.M. Leesnitzer, D.J. Parks, R.K. Bledsoc et al., Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662, Biochemistry 41 (2002), 6640-6650.
121. J. Gregory Powell, X. Wang, B.L. Allard et al., The PAX8/PPARgamma fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARgamma inhibition, Oncogene 23 (2004), 3634-3641.
122. S. Ding and PG. Schultz, Small molecules and future regenerative medicine, Curr Top Med Chem 5 (2005), 383-395.
123. L. Meijer, M. Flajolet and P. Greengard, Pharmacological inhibitors of glycogen synthase kinase 3, Trends Pharmacol Sci 25 (2004), 471-480.
124. S. Ding, T.Y. Wu, A. Brinker et al., Synthetic small molecules that control stem cell fate, Proc Natl. Acad Sci USA 100 (2003), 7632-7637.
125. N. Sato, L. Meijer, L. Skaltsounis, P. Greengard and A.H. Brivardou, Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor, Nat Med 10 (2004), 55-63.
126. J.J. Trowbridge, A. Xenocostas, R.T. Moon and M. Bhatia, Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation, Nat Med 12 (2006), 89-98.
127. P. Kirstetter, K. Anderson, B.T. Porse, S.E. Jacobsen and C. Nerlov, Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol 7 (2006), 1048-1056.
128. M. Scheller, J. Huelsken, F. Rosenbauer et al., Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation, Nat Immunol 7 (2006), 1037-1047.
129. H. Daub, K. Specht and A. Wrich, Strategies to overcome resistance to targeted protein kinase inhibitors, Nat Rev Drug Discov 3 (2004), 1001-1010.
130. L. Zhou, N. An, R.C. Haydon et al., Tyrosine kinase inhibitor STI-571/ Gleevee down-regulates the beta-catenin signaling activity, Cancer Lett 193 (2003), 161-170.
131. M. Lepourcelet, Y.N. Chen, D.S. France et al., Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex, Cancer Cell 5 (2004), 91-102.
132. S. Chen, J.T. Do, Q. Zhang et al., Self-renewal of embryonic stem cells by a small molecule, Proc Natl Acad Sci USA 103 (2006), 17266-17271.